What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Gene
Raymond F. Anton mainly investigates Psychiatry, Alcohol dependence, Randomized controlled trial, Placebo and Naltrexone.
His studies deal with areas such as Anesthesia, Internal medicine, Nicotine and Alcohol abuse as well as Alcohol dependence.
His Acamprosate and Confidence interval study, which is part of a larger body of work in Internal medicine, is frequently linked to Topiramate, bridging the gap between disciplines.
His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Psychotherapist, Clinical trial and Abstinence.
His Placebo study combines topics in areas such as Relapse prevention and Sertraline.
His work on Narcotic antagonist as part of general Naltrexone research is frequently linked to Context, thereby connecting diverse disciplines of science.
His most cited work include:
- Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial (1330 citations)
- The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. (527 citations)
- Topiramate for Treating Alcohol Dependence: A Randomized Controlled Trial (437 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Alcohol dependence, Psychiatry, Internal medicine, Naltrexone and Placebo.
The concepts of his Alcohol dependence study are interwoven with issues in Genetics, Anesthesia, Clinical trial, Randomized controlled trial and Abstinence.
His research investigates the connection between Genetics and topics such as Substance dependence that intersect with issues in Single-nucleotide polymorphism.
His Psychiatry study typically links adjacent topics like Clinical psychology.
His Internal medicine study integrates concerns from other disciplines, such as Ethanol, Endocrinology, Alcohol, Alcohol use disorder and Carbohydrate deficient transferrin.
The Naltrexone study combines topics in areas such as Pharmacology and Opiate.
He most often published in these fields:
- Alcohol dependence (33.45%)
- Psychiatry (32.37%)
- Internal medicine (33.09%)
What were the highlights of his more recent work (between 2017-2021)?
- Alcohol use disorder (10.43%)
- Internal medicine (33.09%)
- Alcohol dependence (33.45%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Alcohol use disorder, Internal medicine, Alcohol dependence, Abstinence and Odds ratio.
Raymond F. Anton has researched Alcohol use disorder in several fields, including Logistic regression, Clinical trial, Acamprosate, Environmental health and Disease.
His research integrates issues of Psychological intervention, Psychiatry, Pharmacogenomics, Animal studies and Motivational enhancement therapy in his study of Acamprosate.
His Internal medicine research is multidisciplinary, relying on both Placebo, Endocrinology and Pharmacogenetics.
His research in Placebo intersects with topics in Smoking cessation and Nicotine.
Many of his studies on Alcohol dependence involve topics that are commonly interrelated, such as Mental health.
Between 2017 and 2021, his most popular works were:
- Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials. (36 citations)
- Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder. (34 citations)
- Transdiagnostic Effects of Ventromedial Prefrontal Cortex Transcranial Magnetic Stimulation on Cue Reactivity (32 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Gene
His primary areas of investigation include Alcohol use disorder, Alcohol dependence, Internal medicine, Abstinence and Clinical trial.
His Alcohol use disorder research integrates issues from Odds ratio and Logistic regression.
Raymond F. Anton specializes in Internal medicine, namely Randomized controlled trial.
His Randomized controlled trial research includes elements of Placebo, Alcohol Abstinence and Naltrexone.
His Naltrexone research incorporates elements of Varenicline, Smoking cessation and Drug/alcohol abstinence.
His research in Clinical trial focuses on subjects like Secondary data, which are connected to Quality of life, Environmental health, Mental health and Surrogate endpoint.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
